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Abstract
Background: The secreted goblet cell protein CLCA1 (chloride channel regulator, calcium-activated-1) is, in
addition to its established role in epithelial chloride conductance regulation, thought to act as a multifunctional
signaling protein, including cellular differentiation pathways and induction of mucus production. Specifically, CLCA1
has recently been shown to modulate early immune responses by regulation of cytokines. Here, we analyze the
role of CLCA1, which is highly expressed and secreted by colon goblet cells, in the course of murine dextran
sodium sulfate-induced colitis.
Findings: We compared Clca1-deficient and wild type mice under unchallenged and DSS-challenged conditions at
various time points, including weight loss, colon weight-length-ratio and histological characterization of inflammation and
regeneration. Expression levels of relevant cytokines, trefoil factor 3 and E-cadherin were assessed via quantitative PCR
and cytometric bead arrays. Lack of CLCA1 was associated with a more than two-fold increased expression of Cxcl-1- and
Il-17-mRNA during DSS colitis. However, no differences were found between Clca1-deficient and wild type mice under
unchallenged or DSS-challenged conditions in terms of clinical findings, disease progression, colitis outcome, epithelial
defects or regeneration.
Conclusions: CLCA1 is involved in the modulation of cytokine responses in the colon, albeit differently than what had
been observed in the lungs. Obviously, the pathways involved depend on the type of challenge, time point or tissue
environment.
Keywords: Clca1-/-, CXCL-1, Keratinocyte chemottractant, CXCL-2, MIP-2α, Inflammation, Signaling molecule, IL-17,
E-cadherin, TFF3
Introduction
The goblet cell-derived protein CLCA1 (chloride chan-
nel regulator, calcium-activated 1) is thought to act as a
multifunctional signaling protein via as yet unidentified
molecular pathways. Originally, CLCA1 had been
thought to modulate epithelial cell chloride conduct-
ance. Subsequent work has shown, however, that it may
also induce airway mucus production through an inter-
leukin (IL)-13-mediated cascade [1] and promote spon-
taneous differentiation while reducing proliferation of
Caco-2 cells [2]. In a similar context, CLCA1 expression
was proposed as a prognostic factor in colorectal cancer
[2, 3].
Recently, CLCA1 was shown to modulate pulmonary
cytokine expression in early immune responses, specific-
ally the pro-inflammatory response of human airway
macrophages in vitro [4], whereas more complex results
have been obtained from mouse models [5, 6]. In Clca1-
deficient (Clca1-/-) mice, experimental Staphylococcus
(S.) aureus pneumonia was associated with decreased re-
sponses of chemokine (C-X-C motif ) ligand (CXCL)-1, a
potent neutrophil chemoattractant, with consequently
decreased neutrophil recruitment [5]. Furthermore, lack
of Clca1 expression yielded reduced responses of the
pro-inflammatory cytokine IL-17. In contrast, following
intranasal ovalbumin or lipopolysaccharide (LPS) chal-
lenge, Clca1-deficiency resulted in increased neutrophil
recruitment preceded by CXCL-1 upregulation in the
LPS model [6]. Thus, the role of CLCA1 in cytokine
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modulation seems to be complex and dependent on the
stimulus used.
Here, we investigated the proposed function of CLCA1
in modulating the early immune response in the colon,
the tissue in which CLCA1 is most highly expressed in
man [7] and mice [8]. We chose the dextran sodium sul-
fate (DSS) challenge model which is commonly used to
study early immune reactions in mouse intestine [9]. In
a previous DSS colitis study, we failed to observe any ef-
fects of Clca1-deficiency on mucus barrier integrity and
mucin gene expression [10] which likely would have af-
fected secondary immune responses. Additionally, recent
studies have indicated that CLCA1 does not play a role
in calcium-activated chloride secretion in the respiratory
tract nor does restoration of reduced Clca1 expression
rectify the cystic fibrosis electrophysiology defect in the
intestine [11, 12]. In light of the absence of such possibly
interfering effects, we postulated that possible differ-
ences in inflammatory parameters during DSS colitis in
the Clca1-/- model would be due to primary CLCA1 ef-
fects on the immune response. We thus compared
Clca1-/- and wild type (WT) mice under unchallenged
and DSS-challenged conditions in terms of key clinical
and histopathological parameters as well as expression
profiles of select cytokines. Furthermore, we determined
expression levels of goblet cell-derived trefoil factor
(Tff )-3, a key regulator in mucosal repair and protection
[13], and E-cadherin (E-cad) which is down-regulated
after Clca1-knock-down in vitro [3].
Materials and methods
Ethics statement, mice and DSS treatment
Clca1-/- and WT mice were given 2.5 % DSS for 24
(24 h-group), 48 h (48 h-group) or for 7 days with 2
consecutive days of water (7 d-group) as described [10].
For ethics statement, selection and treatment see
Additional file 1.
Weight loss, colon weight-length-ratio and sampling
In the 7 d-group, weight loss was determined in the
course of DSS administration and colon weight-length-
ratio at necropsy. Colons of all groups were equally sec-
tioned from proximal to distal for histopathology which
were immediately fixed in 4 % buffered formalin. For Re-
verse Transcriptase-quantitative PCR (RT-qPCR) and
organ culture, sections were opened longitudinally,
flushed with ice-cold Dulbecco’s phosphate buffered sa-
line (biowest, Nuaille, France) and either snap frozen in
liquid nitrogen and stored at – 80 °C or immediately
processed, respectively.
Histopathology
4 μm thick formalin-fixed, paraffin-embedded, hematoxylin
and eosin-stained sections of proximal and distal colon
were evaluated separately by veterinary pathologists
in a blinded fashion according to a scoring scheme
(Additional file 2).
Fig. 1 Similar body weights and colon weight-length-ratios of Clca1-/- and WT mice. a From day 7 on, both DSS-treated genotypes showed a continuous
weight loss to 88.9 ± 0.9 % and 89.5 ± 1.6 % at day 9 whereas the unchallenged mice continued a slight overall weight gain to 103.2 ± 0.9 % and 102.2 ±
1.2 % for Clca1-/- and WT mice, respectively. At day 4, DSS-treated WT mice had higher body weights than the WT controls and the DSS-challenged Clca1-/-
group, the relevance of which, however, remains questionable. n= 10 – 30 per group. b The colon weight-length-ratios increased during DSS colitis
compared to unchallenged controls from 0.027 ± 0.001 and 0.027 ± 0.001 to 0.044 ± 0.002 and 0.043 ± 0.001 for Clca1-/- and WT, respectively, however, with
no difference between the genotypes. n= 10 per group. #p< 0.05 vs. the unchallenged control group. *p< 0.01 between the genotypes
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RNA isolation and reverse transcriptase-qPCR
Total RNA isolation, primer and probe design, RT-qPCR
and data analysis were performed as described [5, 10].
Transcript expression levels of Cxcl-1, Cxcl-2, Il-17, Tnf,
Ifnγ, Tff3 and E-cad were determined and normalized to
the internal reference genes glyceraldehyde-3-phosphate
dehydrogenase (Gapdh), elongation factor-1α (Ef-1α)
and ß-2 microglobulin (B2m) as described [5]. Primers
and probes are listed in Additional file 3.
Cytometric bead array
Colon cultures were established and supernatants proc-
essed as described [14] and stored at -80 °C until further
analysis. Cytokine concentrations of CXCL-1, monocyte
chemoattractant protein (MCP)-1, TNF, IFNγ, IL-1β, -2,
-6, -13 and -17A were determined via cytometric bead
array using a FACSCantoII and the FacsDiva software
(all BD Biosciences, Heidelberg, Germany) as described
[15, 16].
Statistics
Statistical analyses via Mann–Whitney-U test and graph-
ical illustrations were performed using GraphPad PRISM
6 (GraphPad Software Inc., La Jolla, USA) and data are
expressed as mean ± standard error of the mean (SEM)
except for RT-qPCR data. Here, data are expressed as
single value fold change of which a more than two-fold
difference between the genotypes was considered
relevant.
Results and discussion
The percentile body weights declined following day 6 of
DSS application (Fig. 1a) and colon weight-length-ratios
increased (Fig. 1b), without any difference between the
genotypes (Fig. 1) which is in line with the genotype-
independent decrease of stool consistency and increase
of fecal blood content in the DSS colitis model described
earlier [10]. At day 4, DSS-treated WT mice had higher
body weights compared to the DSS-challenged Clca1-/-
Fig. 2 Similar inflammation and regeneration in Clca1-/- and WT mice during DSS colitis. During DSS colitis, the a abundance of neutrophils,
macrophages and lymphocytes, b the histopathology scores for erosion/ulceration and immune cell infiltration increased as well as regeneration
in proximal and distal colon following a 7-day DSS colitis induction and administration of water for 2 consecutive days. No differences were
observed between Clca1-/- and WT mice. c Representative histopathology of proximal and distal colon of DSS-treated Clca1-/- and WT mice and
water controls; neutrophils (arrows), macrophages (asterisks) and lymphocytes (arrowheads). Bars: 20 μm (no DSS and insets) and 50 μm (DSS).
n = 10 per group. #p < 0.05 vs. the unchallenged control group
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mice but also to unchallenged WT controls. In this con-
text and being only 2 % in difference between the geno-
types, this single statistically significant data point is
biologically questionable. Alternatively, in the context of
Ifnγ mRNA decrease at early time points (see below) in
Clca1 -/- mice, this may indicate changes in metabolism
in Clca1-deficient mice only. Importantly, Clca1-
deficiency had no impact on any clinical parameter
tested which is in line with the previous respiratory chal-
lenge model [5].
Histopathologically, Clca1-deficiency did not result in
any effect on the extent and nature of inflammatory
cells, epithelial defects and regeneration. During DSS
colitis, neutrophils, macrophages and lymphocytes
(Fig. 2a and c, insets) as well as erosion/ulceration, im-
mune cell infiltration and regeneration (Fig. 2b and c)
increased in proximal and distal colon, clearly reflecting
the expected inflammation. At 24 und 48 h, no signifi-
cant immune cell infiltrations or histopathologic alter-
ations were observed (Additional file 4). In contrast to
previous studies on airway inflammation in which neu-
trophil responses were either decreased in Clca1-/- mice
after S. aureus infection [5] or increased after LPS chal-
lenge [6], no difference was observed histopathologically
in the colitis model between the genotypes.
As expected, mRNA expressions of Cxcl-1, Cxcl-2, Il-
17, Tnf and Ifnγ (Fig. 3a to e) were overall upregulated
in distal and, sporadically, also in proximal colon during
DSS colitis. These cytokines, except for Il-17, occasion-
ally were slightly elevated at earlier time points.
However, Cxcl-1 and Il-17 (Fig. 3a and c) showed a
greater than two-fold increase of mRNA copy numbers
in distal colon of Clca1-/- compared to WT mice during
colitis. The significance of the transiently lower Ifnγ
Fig. 3 Increase in Cxcl-1- and Il-17-mRNA expression in Clca1-/- mice during DSS-challenge. During DSS colitis, a Cxcl-1, b Cxcl-2, c Il-17, d Tnf and e Ifnγ
were upregulated in the distal colon as the prime target site of DSS and sporadically also in the proximal colon. However, only Cxcl-1 and Il-17 showed a
greater than two-fold increase of mRNA in the distal colon of Clca1-/- compared to WT. At earlier time points, Cxcl-2 was upregulated at 24 h in Clca1-/-
proximal colon and at 48 h in all except for WT distal colon. At 48 h, Cxcl-1, Tnf and Ifnγ were upregulated in proximal colon of Clca1-/- and WT, in proximal
and in distal colon of WT mice, respectively. Ifnγ showed a more than five-fold decrease in the distal colon of DSS-challenged Clca1-/- compared to WT at
24 and also at 48 h. Expression of f Tff3 in distal Clca1-/- and WT colon and of g E-cad in distal Clca1-/- colon was lower during colitis conditions, however,
without difference between the genotypes. Dotted lines indicate a fold change of 0.5 and 2, respectively, as limits for valid statement of lowered or
elevated expressions. A greater than two-fold difference in fold change was considered as relevant difference between the genotypes. Ct, cycle threshold.
Relative quantification and comparison of groups were performed by the ΔΔCt method using unchallenged WT animals as controls (fold change = 1).
n= 9–18 per group
Erickson et al. Journal of Inflammation  (2016) 13:5 Page 4 of 7
Fig. 4 (See legend on next page.)
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expression levels in the distal colon of DSS-challenged
Clca1-/- compared to WT at 24 and 48 h (Fig. 3e) is un-
clear due to lack of histologically evident immune cell
infiltration at these time points (Additional file 4). Ex-
pression of Tff3 mRNA in distal colon of Clca1-/- and
WT mice and of E-cad in distal Clca1-/- colon (Fig. 3f
and g) was lower during colitis, likely due to destruction
of goblet and epithelial cells, respectively, without differ-
ences between the genotypes.
CXCL-1, MCP-1, TNF, IFNγ, IL-1β, -6 and -17A pro-
teins (Fig. 4a to g) were similarly elevated during DSS
colitis, CXCL-1 and MCP-1 also slightly at 24 h of DSS-
challenge in both genotypes, IL-6 at 24 and IL-17A at
48 h in the Clca1 -/- mice.
The cytokines IL-2 and -13 were below the detection
limits at all time points.
Interestingly, differential expression of Cxcl-1
mRNA has also been found in respiratory Clca1-
deficient mouse models [5], consequentially with dif-
ferences in CXCL-1 protein level and neutrophil re-
cruitment [5, 6]. Additionally, Il-17 was also
differentially expressed in one model [5]. The promin-
ently higher mRNA expression levels of Cxcl-1 and
Il-17 in Clca1-/- DSS colitis mice may point towards
initial regulatory events. This may become obvious on
protein level at later time points as had been seen in
the S. aureus pneumonia model [5]. The increase (1.4
fold) of IL-17A in the Clca1 -/- mice of the 7-d group
may confirm this notion.
Despite being opposite to the S. aureus pneumonia
model in which Cxcl-1 and Il-17 were decreased in
Clca1-/- mice [5], the DSS colitis data are in line with in-
creased CXCL-1 responses following respiratory LPS-
challenge [6]. Early Clca1-linked immune response
modulation therefore seems to depend on the stimulus
used. As solely LPS-mediated Toll-like receptor 4 signal-
ing seems to be important for neutrophil recruitment,
control of bacterial translocation and epithelial repair in
acute DSS colitis [17], this model possibly shares similar-
ities with the respiratory LPS challenge.
Our findings confirm the link of CLCA1 to early im-
mune response modulation with a specific effect on
Cxcl-1 and Il-17 albeit not decisive for clinical outcome.
Potentially overlapping effects of CLCA1, including
anion conductance and cellular differentiation, will have
to be taken into account when further deciphering the
interaction of Clca1 with Cxcl-1 and Il-17 in early im-
mune responses.
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Fig. 4 Inflammatory cytokines are similarly upregulated on protein level in DSS colitis between the genotypes. Cytokines were determined on the
protein level in colon supernatant via cytometric bead array and normalized to the respective total protein concentration. a CXCL-1, b MCP-1, c
TNF, d IFNγ, e IL-1β, f IL-6 and g IL-17A were elevated during DSS colitis without any difference between the genotypes. CXCL-1, MCP-1 and IL-6,
the latter only in Clca1-/-, seemed also slightly elevated at 24 h as well as IL-17A in Clca1-/- at 48 h after DSS challenge, however, without statistical
significance between the genotypes. #p < 0.05 vs. the unchallenged control group. n = 9–18 per group. Only if more than 5 mice had detectable
protein values, the group was considered for valid statement of significance
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